Education
About Us
Working with TipRanks
Follow Us
Viking Therapeutics (VKTX)
NASDAQ:VKTX
VKTX Analyst Ratings
Strong Buy
15 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VKTX Stock 12 Month Forecast
Average Price Target
$101.62
▲(288.90% Upside)
| Highest Price Target$164.00 | Average Price Target$101.62 | Lowest Price Target$38.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
William Blair
Reiterated
03/26/25
Morgan Stanley
Reiterated
03/26/25
H.C. Wainwright
Reiterated
03/26/25
Truist Financial
Reiterated
03/12/25
BTIG
Reiterated
03/12/25
J.P. Morgan
Reiterated
03/11/25
Jefferies
Reiterated
03/11/25
B.Riley Financial
Reiterated
03/11/25
Citi
Reiterated
02/24/25
Scotiabank
Initiated
02/12/25
Maxim Group
$120→$70
Buy
167.89%
Upside
Reiterated
02/07/25
Viking Therapeutic (VKTX) PT Lowered to $70 at Maxim GroupMaxim Group analyst Naz Rahman lowered the price target on Viking Therapeutic (NASDAQ: VKTX) to $70.00 (from $120.00) while maintaining a Buy rating.
Raymond James
$122→$125
Buy
378.38%
Upside
Reiterated
02/06/25
Viking Therapeutics price target raised to $125 from $122 at Raymond JamesViking Therapeutics price target raised to $125 from $122 at Raymond James
Stifel Nicolaus
$95
Buy
263.57%
Upside
Reiterated
02/06/25
Viking Therapeutics (VKTX) Gets a Buy from Stifel Nicolaus
Piper Sandler
$74→$71
Buy
171.72%
Upside
Reiterated
02/06/25
Viking Therapeutics price target lowered to $71 from $74 at Piper SandlerViking Therapeutics price target lowered to $71 from $74 at Piper Sandler
Leerink Partners
$118
Buy
351.59%
Upside
Reiterated
02/05/25
Viking Therapeutics: Promising Developments in Clinical Pipeline and Strategic Progress Support Buy Rating
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
William Blair
Reiterated
03/26/25
Morgan Stanley
Reiterated
03/26/25
H.C. Wainwright
Reiterated
03/26/25
Truist Financial
Reiterated
03/12/25
BTIG
Reiterated
03/12/25
J.P. Morgan
Reiterated
03/11/25
Jefferies
Reiterated
03/11/25
B.Riley Financial
Reiterated
03/11/25
Citi
Reiterated
02/24/25
Scotiabank
Initiated
02/12/25
Maxim Group
$120→$70
Buy
167.89%
Upside
Reiterated
02/07/25
Viking Therapeutic (VKTX) PT Lowered to $70 at Maxim GroupMaxim Group analyst Naz Rahman lowered the price target on Viking Therapeutic (NASDAQ: VKTX) to $70.00 (from $120.00) while maintaining a Buy rating.
Raymond James
$122→$125
Buy
378.38%
Upside
Reiterated
02/06/25
Viking Therapeutics price target raised to $125 from $122 at Raymond JamesViking Therapeutics price target raised to $125 from $122 at Raymond James
Stifel Nicolaus
$95
Buy
263.57%
Upside
Reiterated
02/06/25
Viking Therapeutics (VKTX) Gets a Buy from Stifel Nicolaus
Piper Sandler
$74→$71
Buy
171.72%
Upside
Reiterated
02/06/25
Viking Therapeutics price target lowered to $71 from $74 at Piper SandlerViking Therapeutics price target lowered to $71 from $74 at Piper Sandler
Leerink Partners
$118
Buy
351.59%
Upside
Reiterated
02/05/25
Viking Therapeutics: Promising Developments in Clinical Pipeline and Strategic Progress Support Buy Rating
VKTX Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
23
24
24
24
30
Buy
13
12
5
4
6
Hold
0
0
0
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
36
36
29
30
38
Each month's total comprises the sum of three months' worth of ratings.
VKTX Financial Forecast
VKTX Stock Forecast FAQ
What is VKTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Viking Therapeutics’s 12-month average price target is $101.62.
What is VKTX’s upside potential, based on the analysts’ average price target?
Viking Therapeutics has 288.90% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VKTX a Buy, Sell or Hold?
Viking Therapeutics has a consensus rating of Strong Buy which is based on 15 buy ratings, 1 hold ratings and 0 sell ratings.
What is Viking Therapeutics’s price target?
The average price target for Viking Therapeutics is $101.62. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $164.00 ,the lowest forecast is $38.00. The average price target represents 288.90% Increase from the current price of $26.13.
The highest analyst price target is $164.00 ,the lowest forecast is $38.00. The average price target represents 288.90% Increase from the current price of $26.13.
What do analysts say about Viking Therapeutics?
Viking Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of VKTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.